The NLRP3 inflammasome plays a key role in AD progression by increasing the release of the proinflammatory cytokine IL-1β and reducing Aβ phagocytosis, which accelerates Aβ aggregation and senile plaque deposition (47). This evidence concerns the gene IL1B and Alzheimer disease.